Patents by Inventor Harvey Pass

Harvey Pass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLASMA AUTOANTIBODY BIOMARKERS FOR DIAGNOSIS OF LUNG CANCER
    Publication number: 20190004051
    Abstract: An immune-proteomic screening of AAb responses using protein arrays has identified two panels of Aab (antigen/antibody complexes) that can potentially differentiate lung adenocarcinoma from smoker controls as well as CT positive benign lung disease. The resulting biomarkers appear to have high specificity so that high risk subjects with a positive CT screen and a positive serum test should get more invasive test such as needle biopsy for a timely cancer diagnosis, among other advantages.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 3, 2019
    Inventors: Joshua Labaer, Ji Qiu, Jie Wang, Garrick Wallstrom, Jin Park, William Rom, Harvey Pass
  • Compositions and methods for treatment, diagnosis and prognosis of mesothelioma
    Patent number: 9157080
    Abstract: Described herein are compositions and methods for the treatment and diagnosis of mesothelioma, and determination of prognosis of mesothelioma patients after surgical operation. Specifically, the invention relates to microRNA molecules associated with treatment, diagnosis and determination of prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: September 6, 2010
    Date of Patent: October 13, 2015
    Assignee: New York University
    Inventors: Harvey Pass, Moshe Hoshen, Sergey Ivanov
  • COMPOSITIONS AND METHODS FOR PROGNOSIS OF MESOTHELIOMA
    Publication number: 20130123138
    Abstract: Disclosed are compositions and methods for the prognosis of mesothelioma patients after surgical operation. Specifically the disclosure provides microRNA (miRNA) molecules associated with prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom. The disclosure further provides altered expression of miRNAs that are associated with good or poor prognosis of mesothelioma.
    Type: Application
    Filed: June 9, 2011
    Publication date: May 16, 2013
    Inventors: Harvey Pass, Moshe Hoshen, Yaron Goren
  • COMPOSITIONS AND METHODS FOR TREATMENT, DIAGNOSIS AND PROGNONIS OF MESOTHELIOMA
    Publication number: 20120177599
    Abstract: Described herein are compositions and methods for the treatment and diagnosis of mesothelioma, and determination of prognosis of mesothelioma patients after surgical operation. Specifically, the invention relates to microRNA molecules associated with treatment, diagnosis and determination of prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: September 6, 2010
    Publication date: July 12, 2012
    Inventors: Harvey Pass, Moshe Hoshen, Sergey Ivanov
  • COMPOSITIONS AND METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF MESOTHELIOMA
    Publication number: 20110071215
    Abstract: Described herein are compositions and methods for the diagnosis and treatment of mesothelioma patients and the prognosis of mesothelioma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with diagnosis, treatment and prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 26, 2009
    Publication date: March 24, 2011
    Inventors: Harvey Pass, Hila Benjamin, Moshe Hoshen, Sergey Ivanov